Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.38% | 168.21 | 0.7% | $1128.84m | |
| PFE | Pfizer Inc. | -0.56% | 49.58 | 0.9% | $923.07m | |
| ABBV | AbbVie, Inc. | -0.50% | 141.84 | 1.9% | $815.66m | |
| LLY | Eli Lilly & Co. | 2.73% | 318.79 | 1.1% | $806.60m | |
| MRK | Merck & Co., Inc. | 0.91% | 91.41 | 0.7% | $800.09m | |
| BMY | Bristol-Myers Squibb Co. | 0.97% | 74.85 | 1.0% | $652.22m | |
| SIGA | SIGA Technologies, Inc. | 2.10% | 24.83 | 0.0% | $473.99m | |
| AZN | AstraZeneca Plc | 0.05% | 66.77 | 1.0% | $369.83m | |
| GBT | Global Blood Therapeutics, Inc. | 0.09% | 67.06 | 5.6% | $333.03m | |
| GSK | GSK Plc | -1.48% | 34.74 | 0.3% | $280.05m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.02% | 225.83 | 8.2% | $273.71m | |
| VERU | Veru, Inc. | 9.17% | 24.29 | 0.0% | $244.75m | |
| HZNP | Horizon Therapeutics Plc | -2.53% | 62.46 | 5.4% | $214.98m | |
| KRTX | Karuna Therapeutics, Inc. | 0.76% | 265.70 | 0.0% | $206.59m | |
| CCXI | ChemoCentryx, Inc. | 0.14% | 50.93 | 2.9% | $202.60m |
Company Profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.